Dyne Therapeutics Debt 2024

Dyne Therapeutics Aktienanalyse

What does Dyne Therapeutics do?

Dyne Therapeutics Inc. is a US biotechnology company specializing in the development of therapies for genetic muscle diseases (HMDs). The company was founded in 2018 and is headquartered in Waltham, Massachusetts. Dyne Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Dyne Therapeutics's Debt Structure

Dyne Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Dyne Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Dyne Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Dyne Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Dyne Therapeutics stock

What is the debt of Dyne Therapeutics this year?

Dyne Therapeutics has a debt level of -121.63 USD this year.

What was the debt of Dyne Therapeutics compared to the previous year?

The debt of Dyne Therapeutics has increased by -29.33% compared to the previous year dropped.

What are the consequences of high debt for investors in Dyne Therapeutics?

High debt can pose a risk for investors of Dyne Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Dyne Therapeutics?

Low debt means that Dyne Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Dyne Therapeutics affect the company?

An increase in debt of Dyne Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Dyne Therapeutics affect the company?

A reduction in debt of Dyne Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Dyne Therapeutics?

Some factors that can influence the debt of Dyne Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Dyne Therapeutics so important for investors?

The debts of Dyne Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Dyne Therapeutics take to change the debt?

To change the debt, Dyne Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Dyne Therapeutics pay?

Over the past 12 months, Dyne Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dyne Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Dyne Therapeutics?

The current dividend yield of Dyne Therapeutics is .

When does Dyne Therapeutics pay dividends?

Dyne Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Dyne Therapeutics?

Dyne Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Dyne Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Dyne Therapeutics located?

Dyne Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dyne Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dyne Therapeutics from 8/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/21/2024.

When did Dyne Therapeutics pay the last dividend?

The last dividend was paid out on 8/21/2024.

What was the dividend of Dyne Therapeutics in the year 2023?

In the year 2023, Dyne Therapeutics distributed 0 USD as dividends.

In which currency does Dyne Therapeutics pay out the dividend?

The dividends of Dyne Therapeutics are distributed in USD.